FELODIPINEEXTENDED-RELEASE TABLETS
- Product NDC
- 63304-435
- 11-digit product format
- 633040435
- Labeler code
- 63304
- Product ID
- 63304-435_b951455c-c235-4e23-9e21-08672d108726
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- felodipine
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Ranbaxy Pharmaceuticals Inc
- Application
- NDA019834
- Marketing category
- NDA
- Marketing start
- 2008-09-10
- Marketing end
- 0000-00-00
- Substance
- FELODIPINE
- Active strength
- 3 mg/1
- Pharmacologic classes
- Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [CS]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 63304-435-01 | FELODIPINEEXTENDED-RELEASE TABLETS | 100 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 100 | | 2 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| FELODIPINE | ACTIVE INGREDIENT | OL961R6O2C | FELODIPINEEXTENDED-RELEASE TABLETS (FELODIPINE) TABLET, EXTENDED RELEASE [RANBAXY PHARMACEUTICALS INC] | 2 | |
| FELODIPINE | ACTIVE MOIETY | OL961R6O2C | FELODIPINEEXTENDED-RELEASE TABLETS (FELODIPINE) TABLET, EXTENDED RELEASE [RANBAXY PHARMACEUTICALS INC] | 2 | |
| FD&C BLUE NO. 2 | INACTIVE INGREDIENT | L06K8R7DQK | FELODIPINEEXTENDED-RELEASE TABLETS (FELODIPINE) TABLET, EXTENDED RELEASE [RANBAXY PHARMACEUTICALS INC] | 2 | |
| FERRIC OXIDE YELLOW | INACTIVE INGREDIENT | EX438O2MRT | FELODIPINEEXTENDED-RELEASE TABLETS (FELODIPINE) TABLET, EXTENDED RELEASE [RANBAXY PHARMACEUTICALS INC] | 2 | |
| HYDROXYPROPYL CELLULOSE | INACTIVE INGREDIENT | RFW2ET671P | FELODIPINEEXTENDED-RELEASE TABLETS (FELODIPINE) TABLET, EXTENDED RELEASE [RANBAXY PHARMACEUTICALS INC] | 2 | |
| LACTOSE | INACTIVE INGREDIENT | J2B2A4N98G | FELODIPINEEXTENDED-RELEASE TABLETS (FELODIPINE) TABLET, EXTENDED RELEASE [RANBAXY PHARMACEUTICALS INC] | 2 | |
| POLYETHYLENE GLYCOL | INACTIVE INGREDIENT | 3WJQ0SDW1A | FELODIPINEEXTENDED-RELEASE TABLETS (FELODIPINE) TABLET, EXTENDED RELEASE [RANBAXY PHARMACEUTICALS INC] | 2 | |
| SODIUM STEARYL FUMARATE | INACTIVE INGREDIENT | 7CV7WJK4UI | FELODIPINEEXTENDED-RELEASE TABLETS (FELODIPINE) TABLET, EXTENDED RELEASE [RANBAXY PHARMACEUTICALS INC] | 2 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | FELODIPINEEXTENDED-RELEASE TABLETS (FELODIPINE) TABLET, EXTENDED RELEASE [RANBAXY PHARMACEUTICALS INC] | 2 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 63304-435 | FELODIPINEEXTENDED-RELEASE TABLETS (FELODIPINE) TABLET, EXTENDED RELEASE [RANBAXY PHARMACEUTICALS INC] | 2 | Legacy NDC, 1 package rows | 20090911_b951455c-c235-4e23-9e21-08672d108726.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 63304-435-01 | 63304043501 | 100 in 1 BOTTLE | Historical |